BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

657 related articles for article (PubMed ID: 19595349)

  • 21. [Secondary hyperparathyroidism: incidence, clinical presentations, treatment].
    Samokhvalova NA; Romanchishen AF; Gerasimchuk RP; Grinev KM; Zemchenkov AIu
    Vestn Khir Im I I Grek; 2007; 166(5):78-81. PubMed ID: 18154100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Medical-surgical integrated approach in the treatment of non-paraneoplasic hyperparathyroidism: our experience].
    Pulvirenti D; Aikaterini T; Campagna A; Ignaccolo L; Giustolisi N; Costa E
    Clin Ter; 2008; 159(5):307-10. PubMed ID: 18998031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?
    Anderson JL; Vanwoerkom RC; Horne BD; Bair TL; May HT; Lappé DL; Muhlestein JB
    Am Heart J; 2011 Aug; 162(2):331-339.e2. PubMed ID: 21835295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical practice guidelines for severe renal hyperparathyroidism].
    Tominaga Y
    Clin Calcium; 2004 May; 14(5):786-91. PubMed ID: 15577043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cinacalcet treatment in dialysis patients with secondary hyperparathyroidism: effects and open issues.
    Drüeke TB
    Ther Apher Dial; 2008 Oct; 12 Suppl 1():S2-12. PubMed ID: 19032522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Secondary hyperparathyroidism].
    Diaconescu MR; Costea I; Terinte R; Diaconescu S; Covic M; Zbranca E
    Chirurgia (Bucur); 1995; 44(1):27-34. PubMed ID: 7496211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New therapies for uremic secondary hyperparathyroidism.
    Torres PU; Prié D; Beck L; Friedlander G
    J Ren Nutr; 2006 Apr; 16(2):87-99. PubMed ID: 16567265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parathyroid Disorders.
    Sell J; Ramirez S; Partin M
    Am Fam Physician; 2022 Mar; 105(3):289-298. PubMed ID: 35289573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cinacalcet: An oral calcimimetic agent for the management of hyperparathyroidism.
    Dong BJ
    Clin Ther; 2005 Nov; 27(11):1725-51. PubMed ID: 16368445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case 16-2008: A woman with bone pain.
    Kumar HK; Jayaraman M; Modi KD
    N Engl J Med; 2008 Sep; 359(11):1183-4; author reply 1184. PubMed ID: 18784114
    [No Abstract]   [Full Text] [Related]  

  • 31. [Primary hyperparathyroidism].
    Carnevale V; Romagnoli E; Pipino M; Scillitani A; D'Erasmo E; Minisola S; Mazzuoli G
    Clin Ter; 2005; 156(5):211-26. PubMed ID: 16382970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dialysis bone disease associated with secondary hyperparathyroidism].
    Nakazawa R
    Nihon Rinsho; 1992 Jan; 50 Suppl():783-8. PubMed ID: 1578767
    [No Abstract]   [Full Text] [Related]  

  • 33. Early intervention with intravenous or pulse oral vitamin D therapy is more effective in the treatment of secondary hyperparathyroidism.
    Yamada S; Taniguchi M; Tokumoto M; Tsuruya K; Hirakata H; Iida M
    Ther Apher Dial; 2010 Aug; 14(4):424-31. PubMed ID: 20649764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperparathyroidism.
    Bilezikian JP; Bandeira L; Khan A; Cusano NE
    Lancet; 2018 Jan; 391(10116):168-178. PubMed ID: 28923463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parathyroidectomy for tertiary hyperparathyroidism associated with X-linked dominant hypophosphatemic rickets.
    Savio RM; Gosnell JE; Posen S; Reeve TS; Delbridge LW
    Arch Surg; 2004 Feb; 139(2):218-22. PubMed ID: 14769584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Role of minimal invasive surgery for primary and secondary hyperparathyroidism].
    Röösli C; Bortoluzzi L; Linder TE; Müller W
    Laryngorhinootologie; 2009 Jul; 88(7):460-4. PubMed ID: 19177327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary hyperparathyroidism: Skeletal and non-skeletal effects, diagnosis and management.
    Pyram R; Mahajan G; Gliwa A
    Maturitas; 2011 Nov; 70(3):246-55. PubMed ID: 21943558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recent advances in the prevention of cardiovascular morbidity and mortality in end-stage renal disease: role of anemia, hyperparathyroidism and calcifications].
    Del Vecchio L; Pozzoni P; Limardo M; Caruso S; Fortunato M; Pontoriero G; Locatelli F
    G Ital Nefrol; 2007; 24 Suppl 38():25-32. PubMed ID: 17922444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Maxillary, buccal and dental expressions of hyperparathyroidisms].
    Wémeau JL; Cardot-Bauters C
    Presse Med; 2017 Sep; 46(9):845-852. PubMed ID: 28579010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A hemodialysis patient with secondary hyperparathyroidism in whom primary parathyroid adenoma was resected 27 years previously].
    Itoh K; Tanaka M; Matsushita K; Tominaga Y
    Nihon Jinzo Gakkai Shi; 2003 Oct; 45(7):706-12. PubMed ID: 14631767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.